Wednesday Pre-Market Top Gainers $MITO $AMC $BCTX

12.0 months average overall survival benefit, including 13.4 months in patients with 2+ HLA matches and 12.5 months in patients with Grade I/II tumors(1)
Top Responder: 21.4 months survival plus 100% resolution of ‘eye-bulging’ orbital tumor
Compares to 7.2-9.8 months survival in historical comparison treatment trials(2)

SLNO [NASD]

Soleno Therapeutics, Inc.

Healthcare | Diagnostics & Research | USA

2% 82mc 62f

Jun-02-21 08:00AM

Soleno Therapeutics Receives Orphan Drug Designation from FDA for Diazoxide Choline for the Treatment of Glycogen Storage Disease Type 1a

GlobeNewswire +25.49%

Tuesday

VTNR [NASD]

Vertex Energy, Inc.

Energy | Oil & Gas Refining & Marketing | USA

100% 90mc 36f

07:38 AM EDT, 06/01/2021 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Vertex Energy Inc. shares were recently up 55% at $6.19 after more than doubling on Thursday following Wednesday's announcement of a $75 million deal to buy an Alabama refinery from Royal Dutch Shell PLC.
Vertex said the Mobile refinery purchase will be its "largest, most significant transaction ever," positioning it to be "a leading regional supplier of both renewable and conventional products."
Shares closed at $1.78 Wednesday.

May-27-21 05:10AM

Vertex Soars After a $75 Million Deal To Buy Shells Alabama Refinery

Investing.com +165.73%

May-26-21 04:30PM

Vertex Energy To Acquire Alabama Refinery and Related Logistics Assets

ACCESSWIRE

RTK [NASD]

Paratek Pharmaceuticals, Inc.

Healthcare | Biotechnology | USA

2% 400mc 43f

- Oral-only dosing for the Treatment of CABP Expands the Commercial Opportunity for Primary Care Promotion

- Primary Care Market Opportunity for CABP Estimated at Approximately $1.5 Billion

BOSTON, June 01, 2021 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases and for other public health threats for civilian, government and military use, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s supplemental New Drug Application (sNDA) for the oral-only dosing regimen of NUZYRA® for the treatment of adults with CABP.

OEG [NASD]

Orbital Energy Group, Inc.

Utilities | Utilities - Diversified | USA

15% 177mc 38f

Jun-01-21 08:05AM

Orbital Energy Group, Inc.'s Recently Acquired Subsidiary, Gibson Technical Services, Reaches Agreement With TEC On 700-Mile Engineering And Construction Project Across Central Mississippi

PR Newswire

Merch

420 Art is live for Team Winkler on Jeff's website (10% discount code: “AWinkler)

https://www.jeffthe420chef.com/shop?Product+Type=420+Art

Tulip mania art work - (10% Off Code: AlexWinkler)

https://www.annettewinkler.com